Immunity, inflammation and disease · 2026
Diagnostic Value of Neutrophil CD64 in Differentiating Scrub Typhus From Febrile Diseases.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Su Jing, Chen Junyi, Shen Xuan, Zhang Yaoyun, Li Wenya, Qi Jijin, Zhong Qing, Sun Tianyu, Shi Siqi, Zhu Fang, Yan Youde
Аннотация
BACKGROUND: Scrub typhus, lacks specific early symptoms, and traditional serological tests have low sensitivity. This study shows that CD64 has superior diagnostic performance compared to CRP and PCT in bacterial infections.
METHODS: This retrospective study analyzed 242 febrile patients admitted to the Jiangsu Province (Suqian) Hospital (January 2023-December 2024), categorized into non-specific fever (n = 186) and scrub typhus (n = 56). The CD64 expression was quantified via flow cytometry (BD FACS Canto II) within 48 h of admission. ROC analysis evaluated diagnostic performance using AUC, sensitivity, specificity, and Youden index. Mann-Whitney U and Chi-square tests compared groups (SPSS v26.0), with significance at p < 0.05.
RESULTS: The scrub typhus group had significantly higher CD64 levels (median: 2.90 [IQR: 1.00-5.20]) than non-specific fever (0.23 [0.10-0.58], p < 0.001). ROC analysis demonstrated CD64's high discriminatory power: AUC = 0.938 (95% CI: 0.882-0.995) for scrub typhus vs. non-specific fever (sensitivity = 91.7%, specificity = 89.8%). Traditional markers like WBC and lymphocyte percentage showed high discrimination against non-specific fever (AUC = 0.973-0.989).
CONCLUSION: This study shows that CD64 is an efficient biomarker for differentiating scrub typhus from febrile diseases, offering crucial evidence for establishing rapid diagnostic pathways and holding value for early triage of febrile patients.
METHODS: This retrospective study analyzed 242 febrile patients admitted to the Jiangsu Province (Suqian) Hospital (January 2023-December 2024), categorized into non-specific fever (n = 186) and scrub typhus (n = 56). The CD64 expression was quantified via flow cytometry (BD FACS Canto II) within 48 h of admission. ROC analysis evaluated diagnostic performance using AUC, sensitivity, specificity, and Youden index. Mann-Whitney U and Chi-square tests compared groups (SPSS v26.0), with significance at p < 0.05.
RESULTS: The scrub typhus group had significantly higher CD64 levels (median: 2.90 [IQR: 1.00-5.20]) than non-specific fever (0.23 [0.10-0.58], p < 0.001). ROC analysis demonstrated CD64's high discriminatory power: AUC = 0.938 (95% CI: 0.882-0.995) for scrub typhus vs. non-specific fever (sensitivity = 91.7%, specificity = 89.8%). Traditional markers like WBC and lymphocyte percentage showed high discrimination against non-specific fever (AUC = 0.973-0.989).
CONCLUSION: This study shows that CD64 is an efficient biomarker for differentiating scrub typhus from febrile diseases, offering crucial evidence for establishing rapid diagnostic pathways and holding value for early triage of febrile patients.